Herbalife benefits from strong gross margins, a large and experienced global distributor network, and a well‑known brand in nutrition and weight management. The balance sheet has been significantly de‑risked through large debt reduction, moving the company toward a net cash position and improving liquidity. Cash flow from operations remains positive, and recent cuts to capex and buybacks have boosted free cash flow and financial flexibility. On the strategic side, the company is leaning into personalized nutrition, digital platforms, and new product categories, which together offer a credible path to differentiation.

At the same time, the company faces notable risks. Revenue has been declining, and profitability has deteriorated to the point where operating income and EBITDA turned negative in the latest year. Operating expenses, especially SG&A, have surged, raising questions about cost discipline and the payback on growth investments. Equity and retained earnings are still negative, reflecting a legacy of accumulated losses and aggressive capital returns. Reduced investment spending may help near‑term cash flow but could constrain future growth if underdone. Finally, execution and regulatory risks around its direct‑selling model and new technology‑driven offerings remain significant.

Looking ahead, Herbalife appears to be in a transition phase: repairing its balance sheet, preserving cash, and simultaneously attempting a major strategic pivot toward personalized, tech‑enabled nutrition. The company’s underlying product economics and brand remain solid, and its improved leverage and liquidity give it more breathing room. However, the negative trends in revenue, margins, and operating cash flow create a cautious backdrop. The medium‑term trajectory will likely depend on two things: whether management can rein in costs and restore operational efficiency, and whether the new digital and personalized offerings can reignite sustainable growth without overburdening the income statement.